- Home
- Healthcare
- Noninvasive Delivery Vaccine Market
Noninvasive Delivery Vaccine Market Size, Share, Growth, and Industry Analysis, By Type (oral vaccine and nasal spray vaccine), By Application (public and private) and Regional Forecast to 2033
Region: Global | Format: PDF | Report ID: PMI2020 | SKU ID: 26418220 | Pages: 142 | Published : April, 2024 | Base Year: 2024 | Historical Data: 2020 - 2023
Detailed TOC of Global Noninvasive Delivery Vaccine Market Research Report 2024(Status and Outlook)
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Noninvasive Delivery Vaccine
1.2 Key Market Segments
1.2.1 Noninvasive Delivery Vaccine Segment by Type
1.2.2 Noninvasive Delivery Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Noninvasive Delivery Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Noninvasive Delivery Vaccine Market Size (M USD) Estimates and Forecasts (2019-2031)
2.1.2 Global Noninvasive Delivery Vaccine Sales Estimates and Forecasts (2019-2031)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Noninvasive Delivery Vaccine Market Competitive Landscape
3.1 Global Noninvasive Delivery Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Noninvasive Delivery Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Noninvasive Delivery Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Noninvasive Delivery Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Noninvasive Delivery Vaccine Sales Sites, Area Served, Product Type
3.6 Noninvasive Delivery Vaccine Market Competitive Situation and Trends
3.6.1 Noninvasive Delivery Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Noninvasive Delivery Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Noninvasive Delivery Vaccine Industry Chain Analysis
4.1 Noninvasive Delivery Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Noninvasive Delivery Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Noninvasive Delivery Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Noninvasive Delivery Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Noninvasive Delivery Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Noninvasive Delivery Vaccine Price by Type (2019-2024)
7 Noninvasive Delivery Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Noninvasive Delivery Vaccine Market Sales by Application (2019-2024)
7.3 Global Noninvasive Delivery Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Noninvasive Delivery Vaccine Sales Growth Rate by Application (2019-2024)
8 Noninvasive Delivery Vaccine Market Segmentation by Region
8.1 Global Noninvasive Delivery Vaccine Sales by Region
8.1.1 Global Noninvasive Delivery Vaccine Sales by Region
8.1.2 Global Noninvasive Delivery Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Noninvasive Delivery Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Noninvasive Delivery Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Noninvasive Delivery Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Noninvasive Delivery Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Noninvasive Delivery Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Noninvasive Delivery Vaccine Basic Information
9.1.2 Merck Noninvasive Delivery Vaccine Product Overview
9.1.3 Merck Noninvasive Delivery Vaccine Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Noninvasive Delivery Vaccine SWOT Analysis
9.1.6 Merck Recent Developments
9.2 GSK
9.2.1 GSK Noninvasive Delivery Vaccine Basic Information
9.2.2 GSK Noninvasive Delivery Vaccine Product Overview
9.2.3 GSK Noninvasive Delivery Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Noninvasive Delivery Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Noninvasive Delivery Vaccine Basic Information
9.3.2 Sanofi Noninvasive Delivery Vaccine Product Overview
9.3.3 Sanofi Noninvasive Delivery Vaccine Product Market Performance
9.3.4 Sanofi Noninvasive Delivery Vaccine SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Lanzhou Institute
9.4.1 Lanzhou Institute Noninvasive Delivery Vaccine Basic Information
9.4.2 Lanzhou Institute Noninvasive Delivery Vaccine Product Overview
9.4.3 Lanzhou Institute Noninvasive Delivery Vaccine Product Market Performance
9.4.4 Lanzhou Institute Business Overview
9.4.5 Lanzhou Institute Recent Developments
9.5 Serum Institute
9.5.1 Serum Institute Noninvasive Delivery Vaccine Basic Information
9.5.2 Serum Institute Noninvasive Delivery Vaccine Product Overview
9.5.3 Serum Institute Noninvasive Delivery Vaccine Product Market Performance
9.5.4 Serum Institute Business Overview
9.5.5 Serum Institute Recent Developments
9.6 Valneva
9.6.1 Valneva Noninvasive Delivery Vaccine Basic Information
9.6.2 Valneva Noninvasive Delivery Vaccine Product Overview
9.6.3 Valneva Noninvasive Delivery Vaccine Product Market Performance
9.6.4 Valneva Business Overview
9.6.5 Valneva Recent Developments
9.7 Shanghai United Cell
9.7.1 Shanghai United Cell Noninvasive Delivery Vaccine Basic Information
9.7.2 Shanghai United Cell Noninvasive Delivery Vaccine Product Overview
9.7.3 Shanghai United Cell Noninvasive Delivery Vaccine Product Market Performance
9.7.4 Shanghai United Cell Business Overview
9.7.5 Shanghai United Cell Recent Developments
9.8 Bibcol
9.8.1 Bibcol Noninvasive Delivery Vaccine Basic Information
9.8.2 Bibcol Noninvasive Delivery Vaccine Product Overview
9.8.3 Bibcol Noninvasive Delivery Vaccine Product Market Performance
9.8.4 Bibcol Business Overview
9.8.5 Bibcol Recent Developments
9.9 PaxVax
9.9.1 PaxVax Noninvasive Delivery Vaccine Basic Information
9.9.2 PaxVax Noninvasive Delivery Vaccine Product Overview
9.9.3 PaxVax Noninvasive Delivery Vaccine Product Market Performance
9.9.4 PaxVax Business Overview
9.9.5 PaxVax Recent Developments
9.10 Vabiotech
9.10.1 Vabiotech Noninvasive Delivery Vaccine Basic Information
9.10.2 Vabiotech Noninvasive Delivery Vaccine Product Overview
9.10.3 Vabiotech Noninvasive Delivery Vaccine Product Market Performance
9.10.4 Vabiotech Business Overview
9.10.5 Vabiotech Recent Developments
9.11 Tiantan Biological
9.11.1 Tiantan Biological Noninvasive Delivery Vaccine Basic Information
9.11.2 Tiantan Biological Noninvasive Delivery Vaccine Product Overview
9.11.3 Tiantan Biological Noninvasive Delivery Vaccine Product Market Performance
9.11.4 Tiantan Biological Business Overview
9.11.5 Tiantan Biological Recent Developments
9.12 EuBiologics
9.12.1 EuBiologics Noninvasive Delivery Vaccine Basic Information
9.12.2 EuBiologics Noninvasive Delivery Vaccine Product Overview
9.12.3 EuBiologics Noninvasive Delivery Vaccine Product Market Performance
9.12.4 EuBiologics Business Overview
9.12.5 EuBiologics Recent Developments
9.13 Panacea Biotec Ltd
9.13.1 Panacea Biotec Ltd Noninvasive Delivery Vaccine Basic Information
9.13.2 Panacea Biotec Ltd Noninvasive Delivery Vaccine Product Overview
9.13.3 Panacea Biotec Ltd Noninvasive Delivery Vaccine Product Market Performance
9.13.4 Panacea Biotec Ltd Business Overview
9.13.5 Panacea Biotec Ltd Recent Developments
9.14 Bio-Med
9.14.1 Bio-Med Noninvasive Delivery Vaccine Basic Information
9.14.2 Bio-Med Noninvasive Delivery Vaccine Product Overview
9.14.3 Bio-Med Noninvasive Delivery Vaccine Product Market Performance
9.14.4 Bio-Med Business Overview
9.14.5 Bio-Med Recent Developments
9.15 Halfkin Bio-Pharmaceuticals
9.15.1 Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Basic Information
9.15.2 Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Product Overview
9.15.3 Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Product Market Performance
9.15.4 Halfkin Bio-Pharmaceuticals Business Overview
9.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
9.16 AstraZeneca
9.16.1 AstraZeneca Noninvasive Delivery Vaccine Basic Information
9.16.2 AstraZeneca Noninvasive Delivery Vaccine Product Overview
9.16.3 AstraZeneca Noninvasive Delivery Vaccine Product Market Performance
9.16.4 AstraZeneca Business Overview
9.16.5 AstraZeneca Recent Developments
9.17 Cipla
9.17.1 Cipla Noninvasive Delivery Vaccine Basic Information
9.17.2 Cipla Noninvasive Delivery Vaccine Product Overview
9.17.3 Cipla Noninvasive Delivery Vaccine Product Market Performance
9.17.4 Cipla Business Overview
9.17.5 Cipla Recent Developments
9.18 BCHT
9.18.1 BCHT Noninvasive Delivery Vaccine Basic Information
9.18.2 BCHT Noninvasive Delivery Vaccine Product Overview
9.18.3 BCHT Noninvasive Delivery Vaccine Product Market Performance
9.18.4 BCHT Business Overview
9.18.5 BCHT Recent Developments
10 Noninvasive Delivery Vaccine Market Forecast by Region
10.1 Global Noninvasive Delivery Vaccine Market Size Forecast
10.2 Global Noninvasive Delivery Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Noninvasive Delivery Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Noninvasive Delivery Vaccine Market Size Forecast by Region
10.2.4 South America Noninvasive Delivery Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Noninvasive Delivery Vaccine by Country
11 Forecast Market by Type and by Application (2025-2031)
11.1 Global Noninvasive Delivery Vaccine Market Forecast by Type (2025-2031)
11.1.1 Global Forecasted Sales of Noninvasive Delivery Vaccine by Type (2025-2031)
11.1.2 Global Noninvasive Delivery Vaccine Market Size Forecast by Type (2025-2031)
11.1.3 Global Forecasted Price of Noninvasive Delivery Vaccine by Type (2025-2031)
11.2 Global Noninvasive Delivery Vaccine Market Forecast by Application (2025-2031)
11.2.1 Global Noninvasive Delivery Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Noninvasive Delivery Vaccine Market Size (M USD) Forecast by Application (2025-2031)
12 Conclusion and Key Findings